Global tumor board maps investigational options for glioblastoma with MDM2 and EGFR amplifications
A new Oncotarget case report details how the WIN Consortium's international molecular tumor board evaluated investigational EGFR, MDM2, CDK4/6 and ...
A new Oncotarget case report details how the WIN Consortium's international molecular tumor board evaluated investigational EGFR, MDM2, CDK4/6 and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine